RYTM RHYTHM PHARMACEUTICALS, INC.

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

RHYTHM PHARMACEUTICALS, INC. (RYTM) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4/FY 2025 earnings results disclosed via press release dated February 26, 2026 — full financials in Exhibit 99.1
• CFO Hunter C. Smith signed the filing, indicating standard authorized release of financial results

Other RHYTHM PHARMACEUTICALS, INC. 8-K Filings

8-K Mar 16, 2026

8-K Mar 2, 2026

Get deeper insights on RHYTHM PHARMACEUTICALS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.